Biomarkers of Diabetes
Biomarkers are molecular markers used as direct or indirect markers of the extent of a disease. HbA1c is considered as the biomarker in diabetes for assessing the risk factor related to retinopathy, nephropathy and other vascular diseases. Biomarkers enable preventive measures to be applied at the subclinical stage and the responses to preventive or therapeutic measures to be monitored.
- Novel Biomarkers
- Advances in Molecular Diagnostics
- HbA1c Biomarker
Related Conference of Biomarkers of Diabetes
June 24-25, 2025
23rd Global Conference on Diabetes, Endocrinology and Primary Healthcare
Paris, France
September 29-30, 2025
24th International Conference on Diabetes, Nutrition, Obesity and Eating Disorders
Rome, Italy
November 06-07, 2025
34th International Conference on Clinical Diabetes, Diabetic Medication & Treatment
Berlin,
November 10-11, 2025
29th International Conference on Diabetes, Endocrinology and Healthcare
Aix-en-Provence, France
Biomarkers of Diabetes Conference Speakers
Recommended Sessions
- Alternative and Herbal Medicine in Diabetes
- Anti-Diabetic Medication
- Biomarkers of Diabetes
- Cholesterol, High Blood Pressure and Diabetes
- Diabetes and Metabolic Syndrome
- Diabetes Induced Heart Complications
- Diabetes Management and Education
- Diabetes Types and Symptoms
- Diabetic Complications
- Diabetic Nephropathy
- Diabetic Retinopathy
- Diagnostic Approach
- Emerging Focus in Diabetes Research
- Genetic Basis of Diabetes
- Gestational Diabetes
- Hypertension
- Medical Devices and Technologies used in Diabetes Treatment
- Neonatal and Juvenile Diabetes
- Pathophysiology and Diagnosis of Hypertension
- Stem Cell Therapy and Nanotechnology in Diabetes
Related Journals
Are you interested in
- Adrenal and Pituitary Disorders - ENDOCRINOLOGY-2025 (Canada)
- Advances in Diabetes Management - Endocrinology Conference 2025 (France)
- Advances in Endocrinology - ENDOCRINOLOGY-2025 (Canada)
- Advances in Hormone Replacement Therapies - Endocrinology Conference 2025 (France)
- Advances in Insulin and GLP-1 Therapies - Endocrinology Conference 2025 (France)
- AI in Diabetes Risk Prediction - Diabetes AsiaPacific 2025 (Germany)
- Artificial Intelligence in Endocrinology and Diabetes - Endocrinology Conference 2025 (France)
- Artificial Intelligence: The Future for Diabetes Care - Herbal Diabetes 2025 (France)
- Artificial Pancreas - Diabetic Nutrition 2025 (Italy)
- Artificial Pancreas and Closed-Loop Systems - ENDOCRINOLOGY-2025 (Canada)
- Beta Cell Regeneration - Diabetes AsiaPacific 2025 (Germany)
- Biomarker for Diabetes - Global Diabetes 2025 (France)
- Blood Glucose Dynamics and Monitoring - Herbal Diabetes 2025 (France)
- Central Nervous Function in Relation to Obesity and Type 2 Diabetes - Diabetic Nutrition 2025 (Italy)
- Circadian Rhythms and Insulin Sensitivity - Diabetes AsiaPacific 2025 (Germany)
- Clinical and Preclinical Pancreas Immunology and Islet Function - Diabetic Nutrition 2025 (Italy)
- Clinical Care and Education - Herbal Diabetes 2025 (France)
- Clinical Decision Support Systems/Advisors - Diabetic Nutrition 2025 (Italy)
- Clinical Research and Medical Case Reports - Global Diabetes 2025 (France)
- Clinical Trials in Endocrinology and Diabetes - Endocrinology Conference 2025 (France)
- Closed-loop System & Algorithm - Diabetic Nutrition 2025 (Italy)
- Complications of Hormone Replacement Therapy (HRT) - ENDOCRINOLOGY-2025 (Canada)
- Continuous Glucose Monitoring Innovations - Diabetes AsiaPacific 2025 (Germany)
- COVID-19 and Diabetes - Diabetic Nutrition 2025 (Italy)
- COVID-19 and Diabetes, Post-COVID Diabetes - Herbal Diabetes 2025 (France)
- CRISPR and Type 1 Diabetes - Diabetes AsiaPacific 2025 (Germany)
- Diabetes and Cancer Connections - Diabetes AsiaPacific 2025 (Germany)
- Diabetes and Cardiology - Herbal Diabetes 2025 (France)
- Diabetes and Cardiovascular Disease: A Dual Epidemic - Endocrinology Conference 2025 (France)
- Diabetes and Cardiovascular Health - ENDOCRINOLOGY-2025 (Canada)
- Diabetes and Cognitive Decline - Diabetes AsiaPacific 2025 (Germany)
- Diabetes and Epigenetics - Diabetes AsiaPacific 2025 (Germany)
- Diabetes and Kidney Disease: From Pathogenesis to Management - Endocrinology Conference 2025 (France)
- Diabetes Complications: Diagnosis and Management - Endocrinology Conference 2025 (France)
- Diabetes Education and Public Health - ENDOCRINOLOGY-2025 (Canada)
- Diabetes Etiology - Herbal Diabetes 2025 (France)
- Diabetes Genetics, Biomarkers and Epidemiology - Diabetic Nutrition 2025 (Italy)
- Diabetes in Children and Teens - Global Diabetes 2025 (France)
- Diabetes Macrovascular Complications - Diabetic Nutrition 2025 (Italy)
- Diabetes Mechanisms in Obesity and More - Diabetic Nutrition 2025 (Italy)
- Diabetes Mellitus - Herbal Diabetes 2025 (France)
- Diabetes Research and Therapeutics - ENDOCRINOLOGY-2025 (Canada)
- Diabetes Symptoms and Complications - Herbal Diabetes 2025 (France)
- Diabetes Technology and Societal Impact - Diabetic Nutrition 2025 (Italy)
- Diabetes: Advanced Technologies and Treatments - Herbal Diabetes 2025 (France)
- Diabetes: Types and its Complications - Global Diabetes 2025 (France)
- Diabetic Foot and Diabetic Eye Problems - Global Diabetes 2025 (France)
- Diabetic Nephropathy - Herbal Diabetes 2025 (France)
- Diabetic Nutrition and Diet - Herbal Diabetes 2025 (France)
- Diabetic Retinopathy - Herbal Diabetes 2025 (France)
- Diabetic Retinopathy and Nephropathy - Global Diabetes 2025 (France)
- Diabetic Retinopathy Detection Advances - Diabetes AsiaPacific 2025 (Germany)
- Digital Diabetes Health - Diabetic Nutrition 2025 (Italy)
- Digital Diabetes Health - Diabetic Nutrition 2025 (Italy)
- Digital Therapeutics for Diabetes - Diabetes AsiaPacific 2025 (Germany)
- Emerging Therapies in Thyroid Disorders - Endocrinology Conference 2025 (France)
- Emerging Treatments and Technologies - Herbal Diabetes 2025 (France)
- Endocrine and Disorders - Herbal Diabetes 2025 (France)
- Endocrine Complications of Diabetes - ENDOCRINOLOGY-2025 (Canada)
- Endocrine Disease and Cancer - Endocrinology Conference 2025 (France)
- Endocrine Disruptions and Environmental Factors - ENDOCRINOLOGY-2025 (Canada)
- Endocrine Disruptors and Environmental Health - Endocrinology Conference 2025 (France)
- Endocrine Pathophysiology - Endocrinology Conference 2025 (France)
- Endocrine Surgery: Challenges and Innovations - Endocrinology Conference 2025 (France)
- Endocrinology and Aging - ENDOCRINOLOGY-2025 (Canada)
- Endocrinology and Endocrine Disorders - Global Diabetes 2025 (France)
- Endocrinology in Special Populations - Endocrinology Conference 2025 (France)
- Gender-Specific Approaches in Endocrinology - Endocrinology Conference 2025 (France)
- Genetics and Thyroid Disorders - Global Diabetes 2025 (France)
- Genomics and Molecular Endocrinology - ENDOCRINOLOGY-2025 (Canada)
- Gestational Diabetes (GDM) - Global Diabetes 2025 (France)
- Gestational Diabetes and Reproductive Endocrinology - ENDOCRINOLOGY-2025 (Canada)
- Global Diabetes Awareness and Education - Endocrinology Conference 2025 (France)
- Global Health Strategies for Diabetes and Endocrine Care - Endocrinology Conference 2025 (France)
- Global Trends in Endocrine and Diabetes Care - ENDOCRINOLOGY-2025 (Canada)
- Gut Microbiome and Diabetes - Diabetes AsiaPacific 2025 (Germany)
- Herbal and Natural therapies in Diabetes - Global Diabetes 2025 (France)
- Hormonal Imbalances and Metabolic Disorders - Endocrinology Conference 2025 (France)
- Hormonal Therapies for Menopause and Aging - Endocrinology Conference 2025 (France)
- Human Weight Regulation and Obesity - Diabetic Nutrition 2025 (Italy)
- Hyperglycemia and Hypoglycemia - Global Diabetes 2025 (France)
- Immune Therapies for Type 1 Diabetes - Diabetes AsiaPacific 2025 (Germany)
- Inflammation and Insulin Resistance - Diabetes AsiaPacific 2025 (Germany)
- Innovations in Diabetes Prevention - Endocrinology Conference 2025 (France)
- Innovative Technologies in Endocrinology and Diabetes - ENDOCRINOLOGY-2025 (Canada)
- Innovative Therapies and Drug Development - Endocrinology Conference 2025 (France)
- Insulin Analogues and Glucose Sensors - Global Diabetes 2025 (France)
- Insulin Devices and Diabetes Medications - Global Diabetes 2025 (France)
- Insulin Resistance & Insulin therapy - Herbal Diabetes 2025 (France)
- Integrative and Holistic Approaches - ENDOCRINOLOGY-2025 (Canada)
- Ketosis and Diabetic Ketoacidosis - Global Diabetes 2025 (France)
- Mental Health and Diabetes - Herbal Diabetes 2025 (France)
- Mental Health in Diabetes Care - Endocrinology Conference 2025 (France)
- Metabolic Reprogramming in Diabetes - Diabetes AsiaPacific 2025 (Germany)
- Metabolic Surgery and Endocrine Outcomes - Endocrinology Conference 2025 (France)
- Metabolic Syndrome and Therapeutics - Global Diabetes 2025 (France)
- Microvascular Complications of Diabetes - Diabetic Nutrition 2025 (Italy)
- Molecular and Cellular endocrinology - Global Diabetes 2025 (France)
- Nanotechnology in Diabetes Treatment - Herbal Diabetes 2025 (France)
- Nanotechnology in Diabetes Treatment - Diabetes AsiaPacific 2025 (Germany)
- Neuroendocrinology and the Brain-Hormone Connection - Endocrinology Conference 2025 (France)
- New Insulins & Insulin Pumps - Diabetic Nutrition 2025 (Italy)
- Non-Insulin Based Diabetes Therapies - Diabetic Nutrition 2025 (Italy)
- Nutrition and Diet - Diabetic Nutrition 2025 (Italy)
- Nutrition and Healthy diet - Global Diabetes 2025 (France)
- Obesity and Insulin Resistance - Endocrinology Conference 2025 (France)
- Obesity and Metabolic Syndrome - ENDOCRINOLOGY-2025 (Canada)
- Obesity and Metabolism for Diabetes - Herbal Diabetes 2025 (France)
- Obesity and Weight Management - Global Diabetes 2025 (France)
- Obesity and Weight Management - Endocrinology Conference 2025 (France)
- Osteomyelitis and Pathophysiology - Global Diabetes 2025 (France)
- Pancreas and Islet Cell Transplantation - Global Diabetes 2025 (France)
- Pediatric Endocrinology and Diabetes - ENDOCRINOLOGY-2025 (Canada)
- Pediatric Endocrinology: Advances and Challenges - Endocrinology Conference 2025 (France)
- Peripheral Hormone Action in Health and Disease - Diabetic Nutrition 2025 (Italy)
- Personalized and Precision Medicine in Endocrinology - Endocrinology Conference 2025 (France)
- Personalized Diabetes Management - Diabetes AsiaPacific 2025 (Germany)
- Pharmacogenomics in Diabetes - Diabetes AsiaPacific 2025 (Germany)
- Prediabetes to Late-Stage Complicated Diabetes - Herbal Diabetes 2025 (France)
- Rare Endocrine Disorders - ENDOCRINOLOGY-2025 (Canada)
- Risks and Benefits of New Therapies - Herbal Diabetes 2025 (France)
- Senescence and Obesity/Diabetes - Diabetic Nutrition 2025 (Italy)
- SGLT2 Inhibitors in Diabetes: - Diabetes AsiaPacific 2025 (Germany)
- Smart Insulin Delivery Systems - Diabetes AsiaPacific 2025 (Germany)
- Stem Cell Therapy for Diabetes: - Diabetes AsiaPacific 2025 (Germany)
- Stroke, Hypertension and Cardiovascular Diseases - Global Diabetes 2025 (France)
- Technological Advances in Diabetes and Endocrinology - Endocrinology Conference 2025 (France)
- The Role of Gut Microbiota in Endocrinology - Endocrinology Conference 2025 (France)
- Thyroid Disorders: Diagnosis and Management - ENDOCRINOLOGY-2025 (Canada)
- Translational Endocrinology and Diabetes Research - ENDOCRINOLOGY-2025 (Canada)
- Transplantation and Artificial Pancreas - Herbal Diabetes 2025 (France)
- Type I and Type II Diabetes - Global Diabetes 2025 (France)
- Types of Diabetes - Herbal Diabetes 2025 (France)